Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach
Kailyn Valido(Yale University), Caroline A Nelson(Yale University), Alana Deutsch(Yale University), Michael J. Murphy(American Veterinary Medical Association), Brett King(Yale University), Theodore Zaki(Yale University), Vandan Patel(Hackensack Meridian Health), Muhammad H Junejo(Yale University), William Damsky(Yale University), Devisha K Patel(Lenox Hill Hospital), Noel Turner(Yale University)
Cited by 6
Related Papers
Awareness and Ever-Use of Electronic Cigarettes Among U.S. Adults, 2010-2011
|Nicotine & Tobacco Research|2013|397
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
|British Journal of Dermatology|2020|389
Computationally guided personalized targeted ablation of persistent atrial fibrillation
|Nature Biomedical Engineering|2019|318
Compendium of Experimental Cetane Number Data
|Unknown|2004|263
Tofacitinib Citrate for the Treatment of Vitiligo
|JAMA Dermatology|2015|255